Statistics
Publications
24
Citations
7.6K
H-Index
20
Active since
2011
Carl Campos is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and molecular oncology.
Publications per year
2011–2024
24
24
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Şevin Turcan, Daniel Rohle, Anuj Goenka et al. · Nature · 2012 · 2K citations · Full text
Medicine, Cancer Biology, Oncology +14
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle, Janeta Popovici-Müller, Nicolaos Palaskas et al. · Science · 2013 · 1.2K citations
Medicine, Cancer Biology, Oncology +17
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
Alexandra Miller, Ronak Shah, Elena Pentsova et al. · Nature · 2019 · 639 citations
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma
Christian Grommes, Alessandro Pastore, Nicolaos Palaskas et al. · Cancer Discovery · 2017 · 402 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 24